Genomics

🧬Genomics Unit 6 – Epigenomics and Gene Regulation

Epigenomics explores how gene expression changes without altering DNA sequences. It focuses on chemical modifications to DNA and histones that affect chromatin structure and accessibility. These modifications play crucial roles in cell differentiation, development, and disease by regulating gene expression patterns. DNA methylation, histone acetylation, and methylation are key epigenetic marks. They're reversible and respond to environmental factors like diet and stress. Epigenetic processes contribute to cellular memory and identity maintenance. Dysregulation is linked to various diseases, including cancer and neurodevelopmental disorders.

Got a Unit Test this week?

we crunched the numbers and here's the most likely topics on your next test

Key Concepts in Epigenomics

  • Epigenomics studies heritable changes in gene expression not caused by alterations in the DNA sequence itself
  • Involves chemical modifications to DNA and histone proteins that affect chromatin structure and accessibility
  • Plays crucial roles in cell differentiation, development, and disease by regulating gene expression patterns
  • Modifications include DNA methylation, histone acetylation, and histone methylation (H3K4me3, H3K27me3)
  • Epigenetic marks are reversible and can be dynamically regulated in response to environmental factors (diet, stress)
  • Contributes to cellular memory, allowing cells to maintain their identity through cell division
  • Dysregulation of epigenetic processes is associated with various diseases (cancer, neurodevelopmental disorders)

DNA Modifications and Chromatin Structure

  • DNA methylation occurs at cytosine residues, primarily in the context of CpG dinucleotides
    • Catalyzed by DNA methyltransferases (DNMT1, DNMT3A, DNMT3B)
    • Associated with gene silencing and heterochromatin formation
  • Methylated DNA can recruit methyl-CpG binding domain (MBD) proteins, which further compact chromatin
  • DNA demethylation can occur passively during replication or actively through the action of TET enzymes
  • Chromatin exists in two main states: euchromatin (open, transcriptionally active) and heterochromatin (condensed, transcriptionally silent)
  • Nucleosome positioning and histone variants (H2A.Z, H3.3) also influence chromatin accessibility and gene regulation
  • Higher-order chromatin structures, such as topologically associating domains (TADs), play a role in gene regulation

Histone Modifications and Their Effects

  • Histone proteins (H2A, H2B, H3, H4) form the core of nucleosomes, around which DNA is wrapped
  • Post-translational modifications (PTMs) of histone tails alter chromatin structure and recruit effector proteins
  • Histone acetylation, catalyzed by histone acetyltransferases (HATs), is associated with active transcription
    • Acetylation neutralizes the positive charge of lysine residues, weakening histone-DNA interactions
    • Recognized by bromodomain-containing proteins, which promote transcription
  • Histone deacetylases (HDACs) remove acetyl groups, leading to chromatin condensation and gene silencing
  • Histone methylation can have activating or repressive effects depending on the residue and degree of methylation
    • H3K4me3 is associated with active promoters, while H3K27me3 marks repressed genes
    • Catalyzed by histone methyltransferases (HMTs) and removed by histone demethylases (HDMs)
  • Other modifications include phosphorylation, ubiquitination, and sumoylation, each with specific effects on chromatin structure and gene regulation

Gene Regulation Mechanisms

  • Epigenetic modifications work in concert with transcription factors and regulatory elements to control gene expression
  • Promoters, located upstream of genes, contain binding sites for transcription factors and RNA polymerase II
    • Promoter methylation can prevent transcription factor binding and lead to gene silencing
  • Enhancers are distal regulatory elements that interact with promoters to activate transcription
    • Marked by H3K4me1 and H3K27ac, and bound by transcriptional activators (p300, CBP)
  • Insulators, such as CTCF-binding sites, prevent inappropriate interactions between regulatory elements and genes
  • Non-coding RNAs (lncRNAs, miRNAs) can also regulate gene expression through epigenetic mechanisms
    • lncRNAs can recruit chromatin-modifying complexes to specific genomic loci
    • miRNAs can induce chromatin modifications and DNA methylation at target gene promoters
  • Epigenetic regulation is crucial for cell-type-specific gene expression and maintaining cellular identity

Epigenetic Inheritance and Reprogramming

  • Epigenetic marks can be inherited through cell division, allowing for the maintenance of gene expression patterns
    • DNA methylation patterns are faithfully replicated by DNMT1 during DNA replication
    • Histone modifications are propagated through the action of histone chaperones and modifying enzymes
  • Transgenerational epigenetic inheritance occurs when epigenetic marks are passed from parents to offspring
    • Documented in plants and some animal models, but the extent in humans is still debated
  • Epigenetic reprogramming erases and re-establishes epigenetic marks at specific developmental stages
    • Occurs in primordial germ cells and early embryos, resetting the epigenome for totipotency
    • Incomplete reprogramming can lead to epigenetic disorders (Angelman syndrome, Prader-Willi syndrome)
  • Induced pluripotent stem cells (iPSCs) are generated by epigenetic reprogramming of somatic cells
    • Overexpression of Yamanaka factors (OCT4, SOX2, KLF4, c-MYC) induces a pluripotent state
    • Useful for disease modeling, drug screening, and regenerative medicine

Techniques in Epigenomics Research

  • Bisulfite sequencing is used to map DNA methylation at single-base resolution
    • Bisulfite treatment converts unmethylated cytosines to uracil, while methylated cytosines remain unchanged
    • Whole-genome bisulfite sequencing (WGBS) provides a comprehensive view of the methylome
  • Chromatin immunoprecipitation followed by sequencing (ChIP-seq) identifies histone modification patterns and transcription factor binding sites
    • Antibodies specific to the modification or factor of interest are used to enrich for associated DNA fragments
  • Assay for Transposase-Accessible Chromatin using sequencing (ATAC-seq) maps open chromatin regions
    • Transposase Tn5 preferentially inserts adapters into accessible chromatin, which can then be sequenced
  • Chromosome conformation capture techniques (3C, 4C, Hi-C) investigate 3D chromatin interactions
    • Based on the principle of crosslinking, restriction digestion, and ligation of spatially proximal DNA fragments
  • Single-cell epigenomics methods (scBS-seq, scATAC-seq) allow for the study of epigenetic heterogeneity within cell populations
  • Computational tools and databases (ENCODE, Roadmap Epigenomics) are essential for analyzing and interpreting epigenomic data

Applications in Health and Disease

  • Epigenetic alterations are implicated in various diseases, including cancer, neurological disorders, and autoimmune conditions
  • Cancer cells often exhibit global hypomethylation and promoter hypermethylation of tumor suppressor genes
    • Epigenetic biomarkers (SEPT9 methylation in colorectal cancer) can be used for early detection and prognosis
    • Epigenetic therapies, such as DNMT inhibitors (azacitidine) and HDAC inhibitors (vorinostat), are used to treat certain cancers
  • Neurodevelopmental disorders (Rett syndrome, fragile X syndrome) are associated with mutations in epigenetic regulators
    • Epigenetic therapies targeting these pathways are being explored as potential treatments
  • Epigenetic factors contribute to the pathogenesis of autoimmune diseases (rheumatoid arthritis, systemic lupus erythematosus)
    • Altered DNA methylation patterns and histone modifications are observed in immune cells and target tissues
  • Epigenetic age, determined by DNA methylation patterns, is a biomarker of biological aging and disease risk
  • Environmental factors (diet, pollution, stress) can influence the epigenome, contributing to disease susceptibility

Future Directions and Challenges

  • Developing more precise and targeted epigenetic therapies with fewer side effects
    • Selective inhibitors of specific epigenetic enzymes (EZH2, DOT1L) are being investigated
    • Combination therapies targeting multiple epigenetic pathways may improve efficacy
  • Understanding the role of epigenetics in complex diseases and traits, such as obesity, diabetes, and mental health disorders
    • Large-scale epigenome-wide association studies (EWAS) can identify disease-associated epigenetic variants
    • Integrating epigenomic data with other omics data (transcriptomics, proteomics) to elucidate disease mechanisms
  • Exploring the potential of epigenetic biomarkers for personalized medicine and risk prediction
    • Epigenetic signatures could guide treatment decisions and monitor disease progression
  • Investigating the interplay between the epigenome, microbiome, and environment in health and disease
  • Addressing technical challenges, such as standardization of epigenomic assays and data analysis pipelines
    • Developing new technologies for single-cell and spatial epigenomics
    • Improving computational tools for integrative analysis of multi-omics data
  • Considering ethical implications of epigenetic research, particularly in the context of epigenetic inheritance and environmental justice


© 2024 Fiveable Inc. All rights reserved.
AP® and SAT® are trademarks registered by the College Board, which is not affiliated with, and does not endorse this website.

© 2024 Fiveable Inc. All rights reserved.
AP® and SAT® are trademarks registered by the College Board, which is not affiliated with, and does not endorse this website.